Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Onyx HealthcareROCO:6569 +0.51%76 Return-on-Tangible-Asset is 7.27% as of Mar. 2026, which is 37% below its 10-year median of 11.59. GuruFocus rates ROCO:6569 with a GF Score™ of 76/100 and a GF Value™ of NT$129.19 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Onyx Healthcare ranks better than 68.78% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Onyx Healthcare's annualizedNet Income for the quarter that ended in Mar. 2026 was NT$161 Mil. Onyx Healthcare's average total tangible assets for the quarter that ended in Mar. 2026 was NT$2,216 Mil. Therefore, Onyx Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 7.27%.
The historical rank and industry rank for Onyx Healthcare's Return-on-Tangible-Asset or its related term are showing as below:
ROCO:6569'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.27 Med: 11.59 Max: 19.47
Current: 6.7
During the past 13 years, Onyx Healthcare's highest Return-on-Tangible-Asset was 19.47%. The lowest was 5.27%. And the median was 11.59%.
ROCO:6569's Return-on-Tangible-Asset is ranked better than 68.78% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs ROCO:6569: 6.70
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Onyx Healthcare Return-on-Tangible-Asset Related Terms
Onyx Healthcare Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Onyx Healthcare's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6569 vs VEEV, BTSG, HQY: Return-on-Tangible-Asset Comparison
For the Health Information Services subindustry, Onyx Healthcare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Healthcare Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Onyx Healthcare's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 7.27% mean?
Onyx Healthcare (ROCO:6569) has a Return-on-Tangible-Asset of 7.27% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Onyx Healthcare and its competitors. This is 37% below median its historical median of 11.59. Over the past decade, Onyx Healthcare's Return-on-Tangible-Asset has ranged from 5.27 to 19.47. According to the industry distribution chart, Onyx Healthcare ranks #212 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 31.2%.
Is Onyx Healthcare's Return-on-Tangible-Asset too high?
Onyx Healthcare's current Return-on-Tangible-Asset of 7.27% is 37% below median its 10-year median of 11.59. Over the past 10 years, this metric has ranged from a low of 5.27 to a high of 19.47. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. Onyx Healthcare's value of 7.27% is 189.6% above this industry median. Based on the distribution chart, Onyx Healthcare ranks #212 out of 679 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Return-on-Tangible-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #212 out of 679 companies for Return-on-Tangible-Asset. This puts Onyx Healthcare in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.51. Onyx Healthcare's value of 7.27% is 189.6% above this benchmark. Historically, Onyx Healthcare's own Return-on-Tangible-Asset has ranged from 5.27 to 19.47 over the past decade. While the company's 10-year median is 11.59 vs. the industry median of 2.51, Onyx Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current Return-on-Tangible-Asset of 7.27% is 189.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current Return-on-Tangible-Asset is 7.27%, which is 37% below median its own 10-year median of 11.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$129.19, compared to a current price of NT$98.40 — trading 23.8% below its estimated fair value. The current Return-on-Tangible-Asset is 7.27%, which is 37% below median its 10-year median of 11.59 and 189.6% above the Healthcare Providers & Services industry median of 2.51. Onyx Healthcare's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Return-on-Tangible-Asset is 7.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$98.40 is trading 23.8% below its estimated GF Value™ of NT$129.19.
GuruFocus considers Onyx Healthcare to be Modestly Undervalued.
Key valuation signals for ROCO:6569:
Return-on-Tangible-Asset: 7.27% (37% below median its 10-year median of 11.59)
GF Value™: NT$129.19 vs. price of NT$98.40 (23.8% below fair value)
Industry Position: 189.6% above the Healthcare Providers & Services median (#212 of 679)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
76GF Score
Get the complete analysis for ROCO:6569
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
